Medesthetics

MAR-APR 2013

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/111786

Contents of this Issue

Navigation

Page 45 of 90

See melanoma from a new perspective. ��� See more. Know more. Clinically ambiguous PSLs pose a unique diagnostic challenge. Even with years of clinical experience, subjective impressions sometimes don���t provide enough information for a clear biopsy decision. MelaFind�� gives you objective data, for a different perspective on clinically ambiguous PSLs and the most curable melanomas. Examine Lesions Beneath the Surface of the Skin . Works within your current protocols . Multi-spectral technology helps you differentiate clinically ambiguous lesions from melanoma . Enhances clinical decision making . Ultra-high sensitivity with better speci���city than achievable by visualization alone���with or without a dermoscope . Clinically-tested, non-invasive, FDA-approved device Important Safety Information MelaFind�� is intended to be used when a dermatologist chooses to obtain additional information for a decision to biopsy, but MelaFind�� should NOT be used to con���rm a clinical diagnosis of melanoma. As with all tools to provide additional information during skin exams, there is a risk that melanomas will be missed and benign moles will be biopsied. MelaFind�� is indicated for use on clinically atypical cutaneous pigmented skin lesions with a diameter between 2mm and 22mm that are accessible by MelaFind��, suf���ciently pigmented (ie, not for use on nonpigmented or skin-colored lesions), that do not contain a scar or ���brosis consistent with previous trauma, where the skin is intact (ie, non-ulcerated, non-bleeding lesions), that are more than 1cm away from the eye, do not contain foreign matter, and are not on special anatomic sites (ie, not for use on acral, palmar, plantar, mucosal, or subungual areas). 4PVUI#VDLIPVU4Ut4VJUFt*SWJOHUPO /: www.melasciences.com ��.&-"4DJFODFT *OD..*3FW" Learn more about MelaFind�� at mela���nd.com/newperspective

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - MAR-APR 2013